دورية أكاديمية
A Primer to Cost-Effectiveness Analysis in Breast Cancer Imaging: A Review of the Literature.
| العنوان: | A Primer to Cost-Effectiveness Analysis in Breast Cancer Imaging: A Review of the Literature. |
|---|---|
| المؤلفون: | Waller J; Department of Medicine, Drexel University College of Medicine, Philadelphia, USA., DeStefano K; Department of Medicine, Drexel University College of Medicine, Philadelphia, USA., Dempsey J; Department of Medicine, Boston College, Boston, USA., Leckron J; Department of Medicine, Drexel University College of Medicine, Philadelphia, USA., Tucker A; Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, USA., Umair M; Radiology, Northwestern University Feinberg School of Medicine, Chicago, USA. |
| المصدر: | Cureus [Cureus] 2022 Aug 24; Vol. 14 (8), pp. e28356. Date of Electronic Publication: 2022 Aug 24 (Print Publication: 2022). |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Palo Alto, CA : Cureus, Inc. |
| مستخلص: | Currently, there is a multitude of methods for evaluating the costs and benefits of programs, tools, etc. While cost-benefit analysis (CBA) is commonly used, cost-effectiveness analysis (CEA) is a more appropriate method of evaluation in clinical contexts, such as radiology practices, as CEAs use units such as life years gained as opposed to money (as is the case for CBAs). This review examines CEAs performed within the past 15 years to highlight their applications and key findings in the context of medical imaging. In total, 20 articles published between 2006 and 2022 were identified using a PubMed search for keywords including "cost-effectiveness analysis," "breast cancer," and "medical imaging," with studies lacking a substantial discussion of CEA or a related topic being excluded. CEAs have traditionally been criticized for lack of a standard methodology, despite their utility in the detection and treatment of various pathologies. Although mammography and magnetic resonance imaging (MRI) are the preferred and cost-effective imaging modalities for breast cancer, other imaging modalities, such as contrast-enhanced mammography and digital breast tomosynthesis, may be more cost-effective in the appropriate clinical context. Different combinations of mammography and MRI screenings for certain breast cancers may also prove to be more cost-effective compared to current mammography/MRI screening schedules. While CEA has shown potential utility in estimating the costs (per unit of health gained) of different imaging tools, CEA risks ignoring important outcomes not included in the analysis and cannot address if the benefits of the imaging tool exceed its costs, as a CBA would, suggesting the need for combining several economic evaluations for a more complete understanding. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Waller et al.) |
| References: | Eur Radiol. 2016 Jan;26(1):184-90. (PMID: 25929946) BMJ Open. 2020 Jan 6;10(1):e028766. (PMID: 31911508) Med Decis Making. 2018 Apr;38(3):400-422. (PMID: 29587047) BMC Cancer. 2014 Mar 26;14:224. (PMID: 24670067) JAMA. 2016 Sep 13;316(10):1093-103. (PMID: 27623463) J Am Coll Radiol. 2018 Nov;15(11):1536-1546. (PMID: 30057243) AJR Am J Roentgenol. 2014 Nov;203(5):939-44. (PMID: 25341130) J Natl Cancer Inst. 2020 Jun 1;112(6):582-589. (PMID: 31503283) Radiology. 2020 Oct;297(1):40-48. (PMID: 32749212) BMC Health Serv Res. 2006 Feb 20;6:12. (PMID: 16504017) Clin Radiol. 2018 Aug;73(8):715-723. (PMID: 29937340) J Am Coll Radiol. 2020 Apr;17(4):452-461. (PMID: 31790678) Eur Radiol. 2015 Dec;25(12):3629-37. (PMID: 26003789) Cancer. 2013 Mar 15;119(6):1266-76. (PMID: 23184400) J Magn Reson Imaging. 2019 Jun;49(7):e216-e221. (PMID: 30632645) Breast. 2019 Jun;45:82-88. (PMID: 30904701) Oncotarget. 2018 Apr 13;9(28):19836-19846. (PMID: 29731987) |
| فهرسة مساهمة: | Keywords: breast cancer; cost-effectiveness analysis; imaging; mammography; mri |
| تواريخ الأحداث: | Date Created: 20220915 Latest Revision: 20220917 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC9457393 |
| DOI: | 10.7759/cureus.28356 |
| PMID: | 36106225 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!